FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W641203635> ?p ?o ?g. }

• W641203635 abstract "B-cell chronic lymphocytic leukemia (B-CLL) is the most common leukemia among the adult population in western countries and accounts for 30-40% of all leukemias. With survival time ranging from months to decades, the clinical course of individual CLL patients is highly variable. This heterogeneity and in the end the need for means to identify the patients with less favorable disease has encouraged the search for biomarkers that can predict the prognosis. Telomeres are repetitive structures protecting the chromosomal endings and shorten at each cell division. Telomere length (TL) has been indicated as a prognostic factor both in hematological malignancies and solid tumors. In B-CLL, TL is associated with mutation status of the immunoglobulin heavy chain variable (IGHV) gene and with clinical course. In the present thesis the main aim was to evaluate TL as a biomarker in B-CLL using a quantitative PCR-based method for TL determination. In paper I, TL was shown to be a prognostic factor for stage A and stage B/C patients, whereas IGHV mutation status predicted outcome only in stage A patients. Moreover, IGHV mutated CLL cases were subdivided by TL into two groups with different prognosis, a subdivision not seen for unmutated cases. Interestingly, the IGHV-mutated group with short telomeres had en overall survival close to that of the unmutated cases. Thus, a combination of IGHV mutation status and telomere length gave an improved subclassification of CLL identifying previously unrecognized patient groups with different outcomes. TL correlates with cellular origin of B-cell malignancies in relation to the germinal center (GC). In paper II different B-cell lymphoma/leukemia subtypes were analyzed. Shortest telomeres were found in IGHV unmutated CLLs, differing significantly from IGHV mutated cases. Contrary to this, mantle cell lymphomas (MCL) demonstrated similar TL regardless of IGHV mutation status. TL differed significantly between GC-like and non-GC-like diffuse large B-cell lymphomas (DLBCL) and follicular lymphomas (FL) had shorter telomeres than GC-like DLBCL. Hairy cell leukemias, which display Ig gene intraclonal heterogeneity, had longer telomeres than FLs and non-GC-DLBCL, but shorter than GC-DLBCL. In conclusion, TL seemed not to simply correlate with GC origin. Paper III presents a B-CLL cohort assessed for TL, genomic aberrations, IGHV mutation status, CD38 and ZAP-70 expression. An inverse correlation existed between TL and IGHV homology, CD38 and ZAP-70 expression. The presence of genomic aberrations was similar among patients regardless of TL. In contrast, 13q deletion, a favorable biomarker, was more frequent in patients with long telomeres, while 11q and 17p deletions (markers of less favorable outcome) were more frequent in the subgroup with short telomeres. In paper IV a large group of mainly indolent CLL cases from a population based cohort was studied again showing an association between TL and prognosis, especially in “good” prognosis cases as defined by other biomarkers. Multivariate analysis indicated a strong connection between IGHV mutation status, lipoprotein lipase (LPL) expression and TL. A comparison of TL in diagnostic and follow up samples demonstrated a significant correlation, and also in the follow samples TL constituted a significant biomarker for survival." @default.
• W641203635 created "2016-06-24" @default.
• W641203635 creator A5007514996 @default.
• W641203635 creator A5018989565 @default.
• W641203635 creator A5020784348 @default.
• W641203635 creator A5030094794 @default.
• W641203635 creator A5031152423 @default.
• W641203635 creator A5035468292 @default.
• W641203635 creator A5053724671 @default.
• W641203635 creator A5054258973 @default.
• W641203635 creator A5074282617 @default.
• W641203635 creator A5075241830 @default.
• W641203635 creator A5087740553 @default.
• W641203635 date "2011-01-01" @default.
• W641203635 modified "2023-09-27" @default.
• W641203635 title "Telomere length is a robust prognostic marker in early chronic lymphocytic leukemia" @default.
• W641203635 hasPublicationYear "2011" @default.
• W641203635 type Work @default.
• W641203635 sameAs 641203635 @default.
• W641203635 citedByCount "0" @default.
• W641203635 crossrefType "journal-article" @default.
• W641203635 hasAuthorship W641203635A5007514996 @default.
• W641203635 hasAuthorship W641203635A5018989565 @default.
• W641203635 hasAuthorship W641203635A5020784348 @default.
• W641203635 hasAuthorship W641203635A5030094794 @default.
• W641203635 hasAuthorship W641203635A5031152423 @default.
• W641203635 hasAuthorship W641203635A5035468292 @default.
• W641203635 hasAuthorship W641203635A5053724671 @default.
• W641203635 hasAuthorship W641203635A5054258973 @default.
• W641203635 hasAuthorship W641203635A5074282617 @default.
• W641203635 hasAuthorship W641203635A5075241830 @default.
• W641203635 hasAuthorship W641203635A5087740553 @default.
• W641203635 hasConcept C104317684 @default.
• W641203635 hasConcept C126322002 @default.
• W641203635 hasConcept C143998085 @default.
• W641203635 hasConcept C146357865 @default.
• W641203635 hasConcept C151730666 @default.
• W641203635 hasConcept C177336024 @default.
• W641203635 hasConcept C203014093 @default.
• W641203635 hasConcept C2777609679 @default.
• W641203635 hasConcept C2777938653 @default.
• W641203635 hasConcept C2778461978 @default.
• W641203635 hasConcept C2781197716 @default.
• W641203635 hasConcept C2908647359 @default.
• W641203635 hasConcept C54355233 @default.
• W641203635 hasConcept C71924100 @default.
• W641203635 hasConcept C86803240 @default.
• W641203635 hasConcept C99454951 @default.
• W641203635 hasConceptScore W641203635C104317684 @default.
• W641203635 hasConceptScore W641203635C126322002 @default.
• W641203635 hasConceptScore W641203635C143998085 @default.
• W641203635 hasConceptScore W641203635C146357865 @default.
• W641203635 hasConceptScore W641203635C151730666 @default.
• W641203635 hasConceptScore W641203635C177336024 @default.
• W641203635 hasConceptScore W641203635C203014093 @default.
• W641203635 hasConceptScore W641203635C2777609679 @default.
• W641203635 hasConceptScore W641203635C2777938653 @default.
• W641203635 hasConceptScore W641203635C2778461978 @default.
• W641203635 hasConceptScore W641203635C2781197716 @default.
• W641203635 hasConceptScore W641203635C2908647359 @default.
• W641203635 hasConceptScore W641203635C54355233 @default.
• W641203635 hasConceptScore W641203635C71924100 @default.
• W641203635 hasConceptScore W641203635C86803240 @default.
• W641203635 hasConceptScore W641203635C99454951 @default.
• W641203635 hasLocation W6412036351 @default.
• W641203635 hasOpenAccess W641203635 @default.
• W641203635 hasPrimaryLocation W6412036351 @default.
• W641203635 hasRelatedWork W1766895399 @default.
• W641203635 hasRelatedWork W1963748312 @default.
• W641203635 hasRelatedWork W2017666385 @default.
• W641203635 hasRelatedWork W2080166975 @default.
• W641203635 hasRelatedWork W2170215372 @default.
• W641203635 hasRelatedWork W2177152105 @default.
• W641203635 hasRelatedWork W2405789658 @default.
• W641203635 hasRelatedWork W2587348978 @default.
• W641203635 hasRelatedWork W2588383774 @default.
• W641203635 hasRelatedWork W2608552916 @default.
• W641203635 hasRelatedWork W2639428001 @default.
• W641203635 hasRelatedWork W2884437119 @default.
• W641203635 hasRelatedWork W2921130376 @default.
• W641203635 hasRelatedWork W2947343396 @default.
• W641203635 hasRelatedWork W2952193510 @default.
• W641203635 hasRelatedWork W2996002477 @default.
• W641203635 hasRelatedWork W3024934364 @default.
• W641203635 hasRelatedWork W3111689939 @default.
• W641203635 hasRelatedWork W3196202188 @default.
• W641203635 hasRelatedWork W2840587944 @default.
• W641203635 isParatext "false" @default.
• W641203635 isRetracted "false" @default.
• W641203635 magId "641203635" @default.
• W641203635 workType "article" @default.